The purpose of this study was to test the hypothesis that an intact cerebellar fastigial nucleus (CFN) is necessary for the hyperpnea to meet the gas exchange needs of submaximal exercise. Bilateral stainless steel microtubules were implanted in the cerebellum inside (n = 12) or outside (n = 2) the CFN for injection (0.5 to 10 ul) of the neurotoxin ibotenic acid. All goats had difficulty maintaining normal posture and walking for up to one month after the implantation of the microtubules, and again for hours or days after injecting the neurotoxin. Post mortem histology indicated there were 55% fewer living neurons (Table 1A , P < .001, n = 9, 3720 ± 553 vs.1670 ± 192) in the CFN of the experimental goats compared to a control group of goats. As is typical for goats (12, 33), prior to implantation of the microtubules, the decrease in PaCO 2 from rest during mild and moderate treadmill exercise was 2.0 ± 0.39 and 3.5 ± 0.45 mmHg, respectively. Implantation of the microtubules did not significantly change this exercise hyperventilation. However, neurotoxic lesioning with 10 ul ibotenic acid lesions significantly (P < .05) attenuated the decrease in PaCO 2 by 1.3 and 2.8 mmHg at the first and second workload respectively. The modest attenuation of the exercise hypocapnia at both workloads in CFN lesioned goats suggests that the CFN is part of the control system that enables the ventilatory response to meet the gas exchange requirements of submaximal exercise.
INTRODUCTION
Exercise hyperpnea refers to the increase in breathing during exercise that is necessary to replenish the O 2 extracted from the blood and eliminate the CO 2 produced by the tissues. In some species the hyperpnea also contributes to the regulation of body temperature. The hallmarks of this hyperpnea in humans are: 1. the three-phased temporal pattern of expired pulmonary ventilation (V E ) (a rapid increase followed by a slow increase and finally a steady state), 2. a curve-linear relationship between V E , alveolar ventilation (V A ), and VO 2 (oxygen consumption/metabolic rate), and 3. the near homeostasis of blood gases throughout submaximal exercise (8, 9, 22, 39) . At 60% of maximal VO 2, V E begins to increase at a greater rate than VO 2 in humans. The homeostasis of blood gases at submaximal exercise is specific to humans as other species hyperventilate at both submaximal and maximal exercise For over a century numerous studies have attempted to identify the mechanism or signal that mediates the exercise hyperpnea. Numerous hypotheses have been proposed and data were obtained that appeared to be consistent with each hypothesis. However, data from all studies on any single hypothesis have never unequivocally supported any hypothesis; thus the mechanism mediating the hyperpnea remains obscure (6, 7, 8, 9, 11, 12, 21, 22, 23, 28, 29, 38, 39) .
One hypothesis that warrants further investigation is that the cerebellar fastigial nucleus (CFN) is important to the exercise hyperpnea. Several studies have demonstrated (32) showed that humans imagining exercise under hypnosis demonstrated a bilateral activation of the cerebellum in the area of the CFN. In addition, Dormer et al. provided evidence that lesioning the CFN in dogs reduced heart rate and blood pressure during treadmill exercise (1, 10) . Based on these studies, it is conceivable that the CFN is involved in the modulating the exercise hyperpnea. The purpose of the present study was to test the hypothesis that an intact CFN is necessary for the normal ventilatory response required to meet the gas exchange requirements submaximal exercise.
METHODS
Data were obtained on 13 female and 1 male adult goats weighing 44.2 ± 3.7 kg.
The goats were housed and studied in an environmental chamber with a fixed ambient temperature and photoperiod. All goats were allowed free access to hay and water, except for periods of study. All aspects of the study were reviewed and approved by the Medical College of Wisconsin Animal Care Committee before the studies were initiated.
Experimental Design
To assess the role of the CFN in the exercise hyperpnea, the goats were studied at rest and during exercise after: 1. an initial instrumentation surgery, 2. subsequent chronic bilateral implantation of microtubules into the CFN, 3. unilateral or bilateral injection of Page 4 of 33 the serotonin receptor antagonist methysergide into the CFN, and 4. creating lesions by injection of the neurotoxin, ibotenic acid. Ibotenic acid has been used to extensively to create lesions to gain insight into physiologic control mechanisms (18, 33) and this neurotoxin was our initial choice for the present study. However, as detailed in the results, the dramatic effects of this neurotoxin on posture and locomotion prevented obtaining data immediately after the lesion was created. Therefore, we decided to create reversible neuronal dysfunction in the CFN. We chose to utilize the reversible serotonin receptor antagonist methysergide because of the high density of serotonin receptor neurons in the CFN (13, 14) , which we have also documented for goats (unpublished findings). As reported elsewhere (25) , eight of these same goats were also initially studied after implantation of the microtubules to ascertain the physiologic effect of creating a focal acidosis in the CFN.
Surgical Procedures
Instrumentation Surgery -An initial surgery was performed to elevate a 5 cm segment of the carotid arteries. In this and a subsequent surgery, the goats were anesthetized initially with a combination of ketamine and xylazine, intubated, and mechanically ventilated. Throughout surgery anesthesia was maintained with 1-1.5% halothane in oxygen. Under sterile conditions, the carotid arteries were isolated from the vagi, elevated superficial to the muscle, and the skin sutured. After surgery, the goats received ceftifur sodium (2 mg/kg) daily as an antibiotic for 1 week.
Microtubule Implantation Surgery -After D 3 weeks, a second surgery was performed to chronically implant 2 microtubules into the CFN (n = 12) or elsewhere in the cerebellum as a control (n = 2). Arterial blood pressure (BP), heart rate (HR), and rectal temperature (T R ) were continuously monitored throughout the duration of surgery.
An occipital craniotomy was created, and the dura mater was excised to expose the dorsal cerebellum and dorsal aspect of the medulla for visualization of obex. The dorsal surface of the medulla, obex, and the midline were all used as reference points for stereotaxic coordinates in the dorso-ventral, rostro-caudal, and medio-lateral planes. The microtubules were made of 18-gauge stainless steel tubes that were cut to 70 mm in length. The tip of the microtubules were placed at obex, 45 degrees from the horizontal plane, and then raised 18-21 mm above obex and 1-2 mm lateral to the midline. We then advanced the microtubules with the use of a micromanipulator until the tip made contact with the dorsal surface of the cerebellum which served as our zero point for microtubules advancement into the cerebellum. An electrical simulating electrode was inserted through the microtubules and extended 2 mm beyond the tip of the microtubules. All but the last 1mm of the stimulating electrode was insulated. The electrical stimulation electrode was grounded directly to the microtubules or at a site on the neck of the goat. We used a Grass SD9 square pulse stimulator to deliver an 80Hz, 5V, 1 ms pulse width, 200 ms duration, and a 2 ms delay for 30 sec (1, 35, 36) . We began to electrically stimulate the tissue 10 mm from the dorsal surface of the cerebellum and continued to advance the microtubules and stimulating electrode in 1 or 2 mm increments until electrical stimulation elicited an increase in BP and HR. Other studies have also shown these increases in BP and HR when the rostral CFN (rCFN) is electrically stimulated. At this location the Microtubules were secured with screws and dental acrylic to the bone (1, 35, 36) . 
Exercise Protocol and Physiologic Measurements
The ventilatory response to exercise was studied for several days before and after 4 weeks of recovery from microtubules implantation surgery. For these studies, the goats stood on a treadmill for a 30 minute rest period and then walked for 4 minutes at 1.8 mph at 5% grade, followed by 4 minutes at 1.8 mph at 15% grade. During some studies (n = 9), we only recorded BP and HR and sampled 2 cc of arterial blood in duplicate between 3 and 5 and 28 and 30 minutes of the rest period, and in triplicate between 2 and 3.5 minutes of each workload (non mask). Non mask studies were predicated on the history of this laboratory where humans and ponies were studied during exercise without a mask, because of the potential that the mask would be a confounding factor in the ventilatory response to exercise (33) . In separate studies (n = 6), we taped a tight-fitting custom breathing mask to the snout, and attached a two-way breathing valve to the mask.
Inspiratory airflow was monitored continuously with a pneumotachograph attached to the Page 7 of 33 inspiratory side of the two-way breathing valve. In some of these studies (n = 3) we also collected expired gas in a tissot spirometer and analyzed it for the fractions of expired CO 2 and O 2 in order to calculate VO 2. The data were recorded on a Pentium 3 computer by the data collection program Windaq.
Methysergide Studies
The goats were monitored (pulmonary ventilation (V I ), breathing frequency (f), tidal volume (V T ), BP, and HR) during rest as previously mentioned for 30 minutes, during which 2 sets of arterial blood samples were drawn to measure arterial partial 
Ibotenic Acid Studies
To create neurotoxic lesions either a 0.5, 1, 5, or a 10 ul Hamilton microsyringe was attached to a 20 gauge 70 mm stainless steel injection tube. After the tubes were loaded with 50 mM ibotenic acid, the tube was inserted down the inner lumen of the 70 Page 8 of 33 mm microtubules and the injection was completed over 30 seconds. After an hour, the procedure was repeated on the contralateral side. The initial volume injected was always 0.5 ul, because we anticipated that the lesions could cause difficulty in maintaining posture and ambulation. Only one volume was injected on any day and usually the injections were at weekly intervals. We progressively increased the volume of injection in hopes of maximizing the size of the lesion. After the neurotoxin injections, goats usually had difficulty standing; thus post-injection exercise studies were not completed until 24 to 48 hours later, and then for several days thereafter.
Histological Studies
After completion of these protocols the animals were euthanized (Beuthanasia) and the brain was found that in goats where microtubules were implanted into different medullary nuclei but no ibotenic acid was injected, the tissue disruption was confined to a distance of approximately 0.5 mm surrounding the microtubule tract. In contrast, at medullary sites where ibotenic acid was injected, the tissue damage and neuron death extended to at least a distance of 1.5 mm surrounding the microtubules (33) . Based on these data and because it was not possible to distinguish whether the tissue damage beyond the microtubules was caused by microdialysis (25), reversible agents, or ibotenic acid, we will refer to all damage beyond that of the microtubules itself as due to ibotenic acid.
Using hematoxylin and eosin stained slides visualized under a light microscope, living and dead neurons were counted bilaterally in the CFN. Living neurons were defined as those that had an irregular shape, an intact nucleus, and were dark pink or purple in color, where as, dead neurons were defined as those that were round, with no nucleus, and light pink in color.
Data and Statistical Analyses
We calculated V I , BP, HR, f, V T , VO 2. The calculated breath-by-breath data were binned into 15 sec averages for the control and exercise periods. The mean data were statistically analyzed using one-way ANOVA to compare pre implant data to post implant, and post implant to post ibotenic acid data for all of the physiological variables.
A two-way ANOVA was also used to compare the differences in living and dead neurons after ibotenic acid injections to pre implant controls. If the two-way ANOVAs found significance then a Bonferroni post-hoc analysis was used to isolate the specific differences. A one-way ANOVA was used to calculate statistical differences between the different treatments and their effect on the change in PaCO 2 between rest and exercise workloads 1 and 2 ( Figures 2 and 3 , and Tables 2 and 3 ). If one-way ANOVA found significance then the Bonferroni post-hoc analysis was used to isolate the specific differences. An unpaired t-test was used to compare the changes in average weights for goats prior to and after microtubules implantation, to compare masked versus non masked changes in PaCO 2 from rest, and to compare the chronic effect on PaCO 2 at each workload for exercise studies greater than 6 days to studies prior to bilateral injections of 10 ul ibotenic acid ( Figure 3 ). The threshold for significance was set at P < 0.05. , and the average volume destroyed (totally devoid of neurons) by the microtubules and ibotenic acid was 17 ± 0.26 mm was due to the microtubules and 9 mm 3 (7.7%) was due to ibotenic acid. In spite of the finding that the only 14.7% of the CFN was devoid of neurons in the lesioned goats, there was a 55.0% decrease (Table 1A ., P < .001, n = 10) in living neurons in the CFN's of these goats compared to the CFN's of goats that either had microtubules implanted outside the CFN or had no microtubules implanted (1670 ± 192 versus 3720 ± 553), respectively. The large deficit in neurons was due to the neurotoxin destroying some but not all neurons over a large area and because the microtubules were placed in the CFN where in control goats there was the highest density of neurons. There was no correlation between the volume of ibotenic acid or the number of ibotenic acid injections and the total number of living and dead neurons counted.
RESULTS

Histology
Effects of Lesioning Inside or Outside the CFN on Posture, Locomotion, and Behavior
Lesions were created in goats primarily inside (n = 12) or completely outside (n = 2) the CFN. Although these experiments were not designed to study posture, locomotion, or behavior, informal observations were made. Most animals were not able to maintain the normal sternal recumbent posture for several hours to several days after bilateral lesions created by the implantation of microtubules in or outside the CFN, and no animal was able to exercise on the treadmill again for a minimum of 3 weeks after this surgery.
In addition, for several hours to days after ibotenic acid injections experienced difficulty standing, walking, and maintaining a sternal recumbent posture, which is the reason we also created reversible neuronal dysfunction using methysergide. However, injection of methysergide also resulted in difficulty in ambulation and therefore, we were able to obtain acceptable physiologic data on only 4 goats.
Effects of microtubule implantation and ibotenic acid during rest and treadmill exercise
At rest for intact goats V I was 8.2 ± 0.9 liters/minute, f was 20.7 ±1.7 breaths/minute, V T was 0.4 liters/breath, MABP was 70.9 ± 7.1 mmHg, 93.0 ± 9.5 beats./minute, PaCO 2 was 40.1 ±1.4 mmHg, PaO 2 was 103.3 ± 1.3 mmHg, and pH was 7.43 ± 0.01 (Table 2A) . Exercise increased most physiologic variables in a workload dependent manner except for PaCO 2 , PaO 2 , and pH (Table 2B and 2C). PaCO 2 decreased from rest during exercise and there were no significant (P < .05) changes in PaO 2 and pH from rest to exercise. There were no significant attenuations of any physiologic variables due to microtubule implantation or 0.5 ul injections of ibotenic acid (Table 2, P > .05).
Six days after bilateral injections of 10 ul ibotenic acid V T at the second workload was significantly reduced from 1.32 ± 0.27 (Table 2C , P < .05) to 0.58 ± 0.06 liters/breath.
Change in PaCO 2 as an index of the effects of Treadmill Exercise
As in past studies, the change in PaCO 2 between rest and exercise was utilized to determine whether different perturbations affected the capability of the respiratory system to meet the metabolic demands of exercise. Due to concerns that a mask would interfere with the physiologic response to exercise, goats were studied with and without a mask.
Since, there was no significant difference in PaCO 2 , PaO 2 , or pH between masked and nonmasked studies, the data were pooled.
As is typical for goats (18, 33) , prior to implantation, PaCO 2 decreased from rest during mild and moderate treadmill exercise by -2.0 ± 0.39 and -3.5 ± 0.45 mmHg (Table   3 , Fig. 2 , P > .05, n = 11), respectively. This decrease in PaCO2 during the first and second levels of exercise was not significantly altered by microtubule implantation (-2.5 ± 0.39 and. -4.2 ± 0.68 mmHg, Table 2 , Fig. 2 , P > .05, n = 11) or by neurotoxic lesions created by bilateral injections of 0.5 ( Fig. 2 , P > .05, n = 6), 1 ul (-2.4 ± 0.52, and -3.7 ± 0.92 mmHg), or 5 ul ibotenic acid (-1.7 ± 0.64 and -1.4 ± 0.16 mmHg mmHg). However, the chronic effect of bilaterally lesioning the CFN with 10 ul ibotenic acid was a significant ( Table 3 , Fig. 3 , P < .05, n = 4) attenuation of the change in PaCO 2 from rest from -2.9 ± 0.50 to -1.6 ± 0.66, and from -4.2 ± 0.73 to -1.4 ± 0.64 at workloads 1 and 2, respectively. Since in initial goats, the 1 and 5 ul injections had minimal effects on PaCO 2 during exercise, in subsequent goats we by-passed these volumes and proceeded to the 10 ul injections.
In one goat where a lesion was made with 10 ul ibotenic acid in the rCFN the change in PaCO 2 from rest was attenuated from -5.9 to -4.6 (Table 3 ). In contrast, in three goats where only the cCFN was lesioned, and in two goats where 10 ul ibotenic acid was injected outside the CFN there was no consistent affect of the neurotoxin on the exercise PaCO 2 at both workloads (Table 3) .
Physiologic Effects of Injecting Methysergide Inside and Outside the CFN on the Change in PaCO 2 From Rest at Two Workloads of Treadmill Exercise
Methysergide injected bilaterally or unilaterally into the CFN had no consistent effects on PaCO 2 at the first workload. In contrast, at the second workload, bilateral and unilateral injections into the CFN slightly attenuated the change in PaCO 2 from rest to steady state (Table 4 ). This effect of methysergide was also found in one goat when injected outside the CFN.
DISCUSSION
The major findings from these studies are that lesioning the CFN had a modest effect on the capability of the respiratory system to meet the gas exchange demands during exercise. However, lesioning the CFN acutely greatly impaired posture and locomotion.
Limitations of This Study
A major challenge in studying the exercise hyperpnea is to create a perturbation in a hypothesized pathway for mediating the hyperpnea and have an animal capable of performing physiologic exercise. In this regard, the present study was comparable to our past study in which we lesioned the dorsal lateral spinal columns of ponies in an attempt to attenuate information from the exercising muscles to the medullary respiratory centers (29) . Both spinal and cerebellar lesions had profound effects on posture and locomotion resulting in nearly a month of recovery before exercise could be performed again. The plasticity required for locomotion may have been accompanied by plasticity in the mediation of the hyperpnea; thus, as for our spinal lesion studies, the pre versus post surgical lesion studies may have underestimated the role of the CFN in the exercise hyperpnea.
We reasoned that compared to the effects of the surgical lesions, the posture and locomotion deficits would be attenuated when we injected methysergide or ibotenic acid to create reversible and irreversible dysfunction respectively. However, even though attenuated, the goats were either unable or had difficulty walking on the treadmill immediately after these injections. As a result, our data base for these studies is limited and the earliest we could obtain data after injection of the neurotoxin was at least 24 hours post injection. These effects of the neurotoxin increased as the injection volume increased, which we anticipated and therefore was the reason that we began with a low volume and progressively increased the volume of the injection. Moreover, the gait after methysergide and the initial studies after ibotenic acid were often abnormal; thus, we are not certain the data reflect the true effect of the neuronal dysfunction on the exercise hyperpnea. However, the marked posture and locomotor effects and the 55% destruction of neurons indicate that the small attenuation of the exercise hyperventilation was not due to the possibility that we utilized too small volumes of injections and or created lesions that were too small. We did not find a relationship between the physiologic effects and the volume of the CFN destroyed or the total deficit in CFN neurons. Similarly, we found in the same goats that the physiologic effects of focal acidosis in the CFN did not correlate with the volume acidified or the magnitude of the acidification (25) . We speculate that the absence of correlation between the physiologic effects and anatomic deficits (neuron deficit and volume destroyed) is in part due to variation between goats in neuronal density in the CFN and the heterogeneous distribution of chemosensitive, glutamate and serotonin neurons in the CFN of goats.
In most of the goats in this study, we previously found that microdialysis induced focal acidosis increased breathing in the rostral CFN and decreased breathing in the caudal CFN. In most of the goats, surgical and neurotoxic lesions were created in both the rostral and caudal CFN; thus it is conceivable that we caused dysfunction in neurons that had opposite effects on the exercise hyperpnea. However, in the few instances when the ibotenic acid and methysergide injection was primarily in either the rostral or caudal CFN, there was no effect on the PaCO 2 response to exercise. In spite of these limitations, we can confidently conclude that a 55.0% reduction in CFN neurons does not dramatically affect the exercise hyperpnea.
Theories of the Exercise Hyperpnea
The mechanism(s) mediating the exercise hyperpnea has not been elucidated. For over a century, hypotheses have been formulated and tested regarding the mechanism(s) mediating the exercise hyperpnea. Many of these can be classified as "neural" in that it has been proposed that the signal originates in the brain (central command) or in the exercising muscles (spinal afferents), and reaches the medullary respiratory centers via neural pathways. Several other theories can be classified as "humoral" in that a byproduct of exercise is sensed by a receptor within the lungs, heart, or carotid bodies, and the receptor then signals the medullary respiratory centers. Data has been found to both support and contradict each theory. Therefore, because several of these pathways had been shown to be capable of affecting breathing, but not critical for the hyperpnea, Yamamoto proposed the "redundancy or occlusion" theory of the hyperpnea. He proposed that multiple mechanisms are capable of mediating the hyperpnea; thus, even if a major pathway is lesioned, an alternative pathway remains to mediate the hyperpnea.
Our laboratory tested this hypothesis by lesioning 3 major proposed pathways (spinal afferent, lung, carotid bodies) in ponies and we found that exercise hyperpnea was accentuated rather than attenuated; thus, support for this theory was not obtained.
As summarized earlier, the recent findings of the Patterson group (32) and Dormer et al. (10) suggested that the CFN might be critical to a normal exercise hyperpnea. Within the limitations of our study, the hypothesis was not validated. If the CFN was critical, then rather than a very modest attenuation of the exercise hyperventilation, we should have found hypoventilation. Conceivably, the slight attenuation of the hyperventilation we observed may reflect a "coordination" role the CFN exerts for all neural and humoral stimuli that change during exercise. In this respect, the CFN differs from the medullary raphe nucleus, the retrotrapezoid nucleus, the facial nucleus, and the paragigantocellularis reticularis nuclei, because we have previously shown that lesions in each of these nuclei did not have even the small effect presently observed (18, 33) . Finally, because of the potential for redundancy in the exercise hyperpnea mechanism as proposed by Yamamoto (38), other pathways for mediation of the exercise response may have compensated for lesioning of the CFN. Or with lesions of other redundant pathways, the CFN might assume a more critical role in mediation of the exercise hyperpnea.
Acute Effects of Methysergide
Geurts et al. showed the localization of four serotonin (5-HT) receptor subtypes in the rat cerebellum and with several residing in the deep cerebellar nuclei (CFN, interpositus, dentate) (14) . Gardette et al. demonstrated in vitro that 5-HT increased the spontaneous firing rate of the deep cerebellar nuclei in 91% of the tested cells by 109% (13) . In a series of studies Mitchell and colleagues (15, 16, 17 , and 26) demonstrated that 5-HT released from the raphe is necessary for the short-term modulation of exercise.
However, Fluoxetine (Prozac) a reuptake inhibitor of 5-HT depressed respiratory control at rest, but had minimal effects during exercise in goats when injected intravenously (16) .
These studies suggested that 5-HT may affect the exercise hyperpnea. We therefore tested this hypothesis by blocking 5-HT receptors through injection of methysergide, the non specific 5-HT receptor antagonist directly into the CFN. Due to the low number of animals on whom it was feasible to obtain data and the lack of consistency in those studies, it is difficult to definitively ascribe a role of 5-HT receptors in the exercise response, but any effect would appear to be minor.
Effects of Injecting Methysergide and Ibotenic Acid Into and Outside the CFN on Posture and Locomotion
It is well established that the vermis in which the CFN lies receives visual, auditory, and vestibular input as well as somatic sensory input from the head and proximal parts of the body. The vermis coordinates posture and locomotion via the CFN projections to cortical and brainstem areas, which then give rise to the medial descending systems that control the proximal limbs and muscles of the body. A series of inactivation studies using the GABA agonist muscimol over the last decade have demonstrated that the rostral CFN is involved in the control of posture (2, 20, 24) , while the caudal CFN is involved in the control of visually guided eye movements. Dormer et al. (27, 30, 31) demonstrated in dogs that almost all lesions caused postural and locomotor deficits, but complete recovery from these lesions was achieved within 10 -20 days. Only dogs that had most of the CFN damaged lesions were anxious and uneasy during treadmill running due to nonrecoverable vestibulomotor deficits. (10 ) . The postural and locomotor deficits described in the aforementioned studies were also observed in our goats in the hours and days following injections of ibotenic acid and methysergide inside and outside the CFN; thus our study in goats has confirmed findings in previous studies in rats, dogs, and monkeys.
CONCLUSION
We conclude that the CFN functions in the pathway necessary for the respiratory systems ability to meet the gas exchange requirements of submaximal exercise, but is not the source of the exercise hyperpnea. Additionally, we have reconfirmed that the CFN and the more generally the cerebellum are more important for posture and locomotion. way ANOVA across all groups revealed no significance (P > .05). The * represents significance at P < .05 for exercise studies greater than 6 days following 10 ul ibotenic acid compared to pre 10 ul ibotenic acid exercise as determined by an unpaired t-test. Values are neuron counts measured at each .5 mm intervals lateral to midline for goat cerebellar fastigial nucleus (CFN) that had only microtubule induced lesions and no ibotenic acid induced lesions (n = 1) and goat CFN's that had both microtubule and ibotenic acid (combination induced lesions) induced lesions (n = 9), as well as, the average neuron counts for control animals (n = 5) and the average neuron counts for combination induced lesions. The (*) represents significance for 2-way ANOVA at each .5 mm lateral to midline on the average neuron counts for ibotenic acid lesioned CFN's (n = 9) compared to control CFN's (n = 5). Values are means for the last 4 minutes of control and 4 minutes of treadmill exercise at each workload for pulmonary ventilation (V I ), breathing frequency (f), tidal volume(V T ), mean arterial blood pressure (MABP), heart rate (HR), arterial PCO 2 (PaCO 2 ), arterial PO 2 (PaO 2 ), and pH ± the standard error of the mean. The values for blood gases are values for studies performed with masked exercising goats. The number of animals in each group were pre implant (n = 7), post implant (n = 6), post 0.5 ul ibotenic acid (n = 4), and > 6 days post 10 ul ibo. (n = 4). There was no significance for any variable using a one-way ANOVA at P > .05. However, an unpaired t-test comparing pre-implant to terminal V T found significance at P < .05 is represented by an *. 
